Inhibrx Biosciences (INBX) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 3, 2026, to be held virtually for stockholders of record as of April 7, 2026.

• Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report on Form 10-K, are available online, with paper copies available upon request by May 22, 2026.

Voting matters and shareholder proposals

• Election of two Class II directors, Douglas G. Forsyth and Kimberly Manhard, to serve until the 2029 Annual Meeting.

• Ratification of BDO USA, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

• Provision to transact other business that may properly come before the meeting or any adjournments.

Board of directors and corporate governance

• Board recommends voting "FOR" each of the director nominees and the auditor ratification proposal.